News: Department of Chemistry and Biochemistry
Our high-tech marvels demand rare earth metals and oxides. 51³Ô¹ÏºÚÁÏ researchers are working to make extracting them less toxic and more efficient.
51³Ô¹ÏºÚÁÏ has reached a licensing agreement with Abel Therapeutics, a start-up company that seeks to commercialize the discoveries of biochemistry professor Ernesto Abel-Santos.
Three 51³Ô¹ÏºÚÁÏ scientists will present their work during an Alzheimer's research symposium Nov. 13 on campus.
51³Ô¹ÏºÚÁÏ researcher patents a chemotherapy compound that uses a heavy metal derivative to improve cancer treatment.
Chemistry professor developing treatment to help the good bacteria battle the bad bacteria in your stomach.
Chemistry professors' research aims to improve drugs that are effective at treating cancer but leave patients dealing with terrible side effects.
51³Ô¹ÏºÚÁÏ faculty discoveries have commercial applications with value to the university, the private sector, and, ultimately, you. Learn about 51³Ô¹ÏºÚÁÏ chemistry professor Ernesto Abel-Santos, who is working to move his innovative thinking out of the laboratory and into the boardroom.
51³Ô¹ÏºÚÁÏ's scientists make discoveries and share their findings in prestigious journals. But then what?
Two Millennium Scholars make their marks in the College of Sciences.
Meet Dong-Chan Lee, one of several 51³Ô¹ÏºÚÁÏ recipients of the National Science Foundation’s prestigious CAREER Award, the highly competitive grant designed to establish leadership in education and research.